AI-powered precision medicine in haematology: insights from South Korea

M.KimM.Kim
BulletArticle
RED 2023 Artificial Intelligence
共有する：
リンクをコピーする
AI-powered precision medicine in haematology: insights from South Korea

AI-driven precision haematology tailors treatments for blood disorders in healthcare, employing data-driven insights and predictive analytics to aid in diagnosis, treatment, and monitoring. In this talk at RED 2023, Dr Myungshin Kim, a Professor in the Department of Lab Medicine at Seoul St Mary’s Hospital in South Korea, shares her ongoing research in this area and what it says about the broader trend in the AI-driven transformation of medicine.

共有する：
リンクをコピーする

同じトピックの記事

Metabolism in precision medicine: small molecules unlock opportunities

Dr John Ward on expanding HCV testing to achieve elimination goals

おすすめのトピック

SequencingRED 2020Rare Diseases
次のおすすめ記事
  • C-Suite Perspectives, Event Coverage, Healthcare Transformation, Management, RED 2024
Dr William Morice II’s visions and considerations for building a global diagnostics ecosystem
How Awanui Group drives diagnostic excellence in New Zealand: Q&A with Anoop Singh (Part 1)
  • C-Suite Perspectives, Leaders In Conversation, Management
Awanui Group’s quest to improve lab diagnostics in New Zealand: Q&A with Anoop Singh (Part 1)
‘Real world evidence’ and clinical labs: a brief introduction
  • Healthcare Transformation, Management, Operations, Population Health Management
‘Real world evidence’ and clinical labs: a brief introduction
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
  • Disease Area, Healthcare Transformation, Histopathology, Leaders In Conversation, Management, Oncology, Operations
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
Scroll to Top